Senseonics Holdings, Inc. (SENS) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Senseonics Holdings, Inc. (SENS) closed at USD 8.23 on 2026-10-15, a change of +13.5 % over the past year, with a market capitalization of USD 410.83M.

Senseonics Holdings, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Senseonics Holdings, Inc. key figures

Previous close

USD 8.23 (2026-10-15)

1-year change

+13.5 %

Market cap

USD 410.83M

Enterprise value

USD 330.99M

P/E ratio (trailing)

-3.48

P/E ratio (forward)

-3.98

EPS (trailing)

-2.23

EPS (forward)

-1.95

PEG ratio

n/a

Price to book

4.55

Revenue growth

117.8 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

7.46

Employees

130

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Senseonics Holdings, Inc.

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Senseonics Holdings, Inc. and compare it with other stocks.